
EMSELLA by BTL Industries is an FDA-cleared, noninvasive urinary incontinence treatment that utilizes HIFEM therapy to address pelvic floor weakness. This innovative approach employs High-Intensity Focused Electromagnetic (HIFEM) technology to effectively strengthen the pelvic floor muscles from the inside out — all while you remain fully clothed and comfortably seated in a chair.

Experience reduced urine leakage during coughing, sneezing, laughing, and physical activity with HIFEM therapy. There is a significant improvement on the 1-hour pad test when HIFEM is combined with pelvic floor strengthening exercises, making it an effective urinary incontinence treatment.

Patients reported improved bladder control and reduced urgency episodes following HIFEM therapy, a method known for its effectiveness in urinary incontinence treatment and pelvic floor strengthening.

A pilot randomized controlled trial in postpartum women with urinary incontinence found that HIFEM therapy, when combined with pelvic floor strengthening exercises, significantly reduced urine leakage on the 1-hour pad test, underscoring its effectiveness in postnatal rehabilitation.

HIFEM therapy induces deep pelvic floor muscle contractions that have been shown to enhance bioelectrical muscle activity on surface electromyography, with its effectiveness highlighted in a sham-controlled randomized study. This approach is particularly beneficial for pelvic floor strengthening and is a promising urinary incontinence treatment.

Patients report meaningful improvements across multiple quality-of-life domains, including physical limitations, social interactions, personal relationships, and emotional well-being. A randomized controlled trial of 128 women found that HIFEM therapy, an effective method for pelvic floor strengthening, significantly reduced depressive symptoms and improved self-efficacy beliefs while also providing notable benefits for urinary incontinence treatment.

Among sexually active women, HIFEM therapy has been linked to improvements in arousal, orgasm, and a reduced condition-related impact on intimacy. This pelvic floor strengthening technique has shown promising results in a systematic review of chair-based magnetic stimulation, demonstrating clinically relevant improvements in Female Sexual Function Index (FSFI) scores, with increases ranging from +6.3 to +10.0 points across studies. Additionally, patients have reported heightened sexual desire and improved overall satisfaction following treatment, making it a valuable option for urinary incontinence treatment as well.

EMSELLA utilizes HIFEM therapy to deliver focused electromagnetic energy directly to the pelvic floor, inducing thousands of supramaximal muscle contractions during each session. These contractions facilitate deep neuromuscular stimulation, enhance pelvic floor strengthening, and contribute to effective urinary incontinence treatment by remodeling the pelvic floor and restoring continence control.

Emerging evidence supports the use of HIFEM therapy as an effective urinary incontinence treatment in men following radical prostatectomy. In a study involving 27 men with post-prostatectomy incontinence, this pelvic floor strengthening therapy demonstrated a 60.6% improvement in incontinence scores and a significant reduction in daily pad use at the 1-month follow-up. Importantly, no adverse events were reported, and randomized sham-controlled trials in this population are currently underway.
EMSELLA may offer a complementary approach for men with SSRI-induced ED by utilizing HIFEM therapy to strengthen the pelvic floor muscles, which are crucial for maintaining erection rigidity and independent of the central serotonergic effects of the medication. This innovative treatment bypasses the adherence barrier of traditional pelvic floor strengthening methods—unlike conventional Kegel programs that require consistent daily effort and proper technique, Emsella delivers automated, supramaximal contractions that do not rely on patient motivation or skill. Furthermore, it provides a non-pharmacological option—current management strategies for SSRI-induced ED often include dose reduction, drug switching, or the addition of PDE5 inhibitors (sildenafil), but these approaches may not be feasible for all patients, especially those whose depression is well-managed on their current SSRI regimen. Additionally, this treatment effectively addresses the muscular component of urinary incontinence and ED that persists even when central pharmacological interventions are employed, potentially serving as an adjunct to PDE5 inhibitors or other treatments.
Pelvic floor muscle rehabilitation, including HIFEM therapy, has shown promise for addressing premature ejaculation. By focusing on pelvic floor strengthening through targeted contractions of the bulbospongiosus and ischiocavernosus muscles, men may experience improved ejaculatory control. Clinical studies have demonstrated that these interventions can lead to gains in intracavernous pressure that are comparable to those observed in patients undergoing urinary incontinence treatment for erectile dysfunction.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.